From Medscape Gastroenterology

Coverage from the

International Conference on Viral Hepatitis (ICVH) 2017

October 09 - 10, 2017; Chicago, Illinois

October 09 - 10, 2017 Chicago, Illinois
  • Hepatitis C Cure 'Difficult to Implement' Effective treatments are available for patients with hep C, but bridging the gap between infected patients and a cure can be complicated.

Conference News

Popular News From ICVH 2016

  • New Hep C Treatments Cause Adverse Effects in the Elderly New Hep C Treatments Cause Adverse Effects in the Elderly Direct-acting antiviral medications effectively clear hepatitis C infection in older patients, but they can also frequently cause unwanted events, researchers warn.
  • Shortened Hep C Combo Passes Real-World Test Shortened Hep C Combo Passes Real-World Test An 8-week regimen of combination ledipasvir and sofosbuvir appears to clear the hepatitis C virus as well as a 12-week schedule, even in patients with very high viral loads, new research shows.
  • Rhode Island Hep C Complications Projected to Continue Rhode Island Hep C Complications Projected to Continue High rates of liver complications will persist if Rhode Island's Medicaid program continues to limit coverage of antiviral medications on the basis of fibrosis stage, experts warn.

Medscape Gastroenterology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Board at the Podium

  • Nancy Reau, MD
    Rush University Medical Center, Chicago, Illinois
    Meeting co-chair